NeuroDiscovery Ltd, a neurology-focused biotechnology research and development company, is pleased to announce its 100 per cent subsidiary, NeuroSolutions Ltd, has entered into a one year Master Services Agreement with a US biopharmaceutical company.The Agreement provides for the provision of NeuroSolutions specialist electrophysiology services over a one year period up to the value of approximately AUS$580,000. Initial work plans commence immediately with additional work plans under discussion.NeuroDiscovery's Chairman, Dr Mark Treherne said, "We are delighted that NeuroSolutions have been appointed as an electrophysiology services provider of choice for this major USA biopharmaceutical company. Signing master services agreements ensures that we are able to provide clients with scheduled access to services we provide during the term of the agreement. In addition these contracts assist with underpinning the revenue for NeuroSolutions during the 2008 financial year."For commercially sensitive reasons NeuroDiscovery is not able to name the major biopharmaceutical company.
© Business News 2018. You may share content using the tools provided but do not copy and redistribute.